NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

What is the goal of oral Iron therapy for microcytic anemia?

To increase serum Hgb by 1 g/dL every 2-3 weeks
To normalize MCV values within a month
To double the reticulocyte count in 2 weeks
To reduce TIBC within 6 months

The correct answer is: To increase serum Hgb by 1 g/dL every 2-3 weeks

Oral iron therapy is commonly used to treat microcytic anemia, a type of anemia characterized by small red blood cells. The goal of oral iron therapy is to increase the amount of hemoglobin (Hgb) in the blood by 1 gram per deciliter (g/dL) every 2-3 weeks. This is because low levels of Hgb are a key contributing factor to microcytic anemia. Increases in mean corpuscular volume (MCV) and reticulocyte count are also important measures of improvement, but they are not the primary goal of oral iron therapy. Additionally, reducing the total iron binding capacity (TIBC) is not a goal of oral iron therapy as it is a measure of the amount of iron available in the body, not the effectiveness of the treatment. Therefore, option A is the correct answer.